†According to the study led by Nutrafol in 2023 surveying a total of 2,000 women throughout North America.
*According to IQVIA ProVoice survey for 12 months ending March 31, 2025.
¹Ablon and Kogan. J Drugs Dermat. 2018.
²Stephens et al., JCAD 2022/Nutrafol Data on File, 2020.